Top section
Top section
Bank has done five deals, hopes to reach 20 this year, then much more
Senior hires brought in to serve North American investors
Books multiple times covered as company seeks money for energy investments
More articles
More articles
More articles
-
Scott McLaughlin replaced John Moore, who will stay close as vice-chair of equities -
It could take years to develop a gene therapy to slow aging, but much less for big pharma to scoop up Genflow Biosciences
-
First CB of year receives 'decent' interest, yields minus 2.3%
-
Appointment is part of global plan to cross-sell investment banking services
-
Tech names and spin-offs will dominate the German IPO market this year, with investors drawn to sustainable profits and size
-
Actively managed portfolios failed to outperform indices last year but a lack of alternatives will keep them focused on equities
Sub-sections
shared comment list
